Details emerging in the fake drug scandal indicate that a Congolese company based in Bunia, Northeastern Congo, supplied the batch of antibiotics currently under investigation. Frank Nyakairu & Zurah Nakabugo October 1, 2005 Read the full story at allafrica.com.

The former office manager for a Crafton pharmacist under indictment for selling drugs without prescriptions pleaded guilty yesterday to health care fraud and tax evasion. By Torsten Ove October 1, 2005 Read the full story at post-gazette.com.

Andrew von Eschenbach, the director of the National Cancer Institute, who last week took on the added duties of acting Food and Drug Administration commissioner after the abrupt resignation of Commissioner Lester M. Crawford, said yesterday that he will temporarily step down from his day-to-day leadership of the cancer institute. By Rick Weiss October 1, 2005 Read the full story…

Washington- Doctors and pharmacists have been warned that mix-ups in prescriptions of three drugs with similar names but vastly different effects have led to serious health problems. By the Associated Press September 28, 2005 Read the full story at cleveland.com.

TORONTO (CP) – An Ontario pharmacist and two of his businesses have been charged with allegedly selling a bootleg version of Viagra, the highly recognizable and popular blue pill used to treat erectile dysfunction, RCMP investigators said Tuesday. By Colin Perkel, Canadian Press September 28, 2005 Read the full story at canada.com.

AmerisourceBergen (ABC:NYSE – commentary – research – Cramer's Take) has taken a step toward ensuring that counterfeit drugs never wind up in its system again. By Melissa Davis September 27, 2005 Read the full story at thestreet.com.

WASHINGTON — The new acting chief of the Food and Drug Administration says he will be presiding over a transformation in medicine as scientists come to understand diseases in a more detailed way that could improve doctors' ability to treat patients. By John J. Lumpkin, Associated Press September 25, 2005 Read the full story at washingtonpost.com.

BELGAUM: Believe it or not.   India produces spurious and counterfeit drugs worth Rs 4000 crore in a year.   Nearly every popular drug has a duplicate version, which may worsen the conditions of the patients and even may kill the patients. September 23, 2005 Read the full story at newindiapress.com.